Blueberry Therapeutics Ltd gains final approval for its first clinical trial.
Blueberry has now gained regulatory and ethical approval to run its first clinical trial using its novel nanoparticle delivered spray formulation to rapidly treat onychomycosis (OM) and associated tinea pedis (TP). We plan to start the trial [...]